glp 1 vision loss lawsuit The lawsuits allege Novo Nordisk and Indianapolis-based Eli Lilly and Company downplayed risks associated with popular medications including Ozempic, Wegovy and Lilly's Mounjaro. Read more at the link in bio Ozempic and GLP-1 NAION Lawsuits

Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RH, et al

With our commitment to excellence, we ensure your well-being by providing top-notch pharmaceutical solutions

The page is research-only and does not provide dosing, clinical, diagnostic, therapeutic, veterinary, or human-use guidance

Exenatide (EXE) (2 mg weekly), Dapagliflozin (DAPA) (10 mg daily), Exenatide + Dapagliflozin (2 mg weekly/10 mg daily), Dapagliflozin (10 mg) + Metformin (MET) (2000 mg extended release daily), or Phentermine (7.5 mg)/Topiramate were given to the patients for 24 weeks (46 mg extended release daily)

GLP-1 Weight Loss Program Comprehensive medically supervised weight management using FDA-approved GLP-1 medications with weekly check-ins and blood work monitoring

It's truly a versatile molecule that can lift multiple aspects of your health simultaneously